Tag Archives: ADMP

Adamis Pharma (ADMP) Receives a Rating Update from a Top Analyst

Maxim Group analyst Jason McCarthy maintained a Hold rating on Adamis Pharma (ADMP – Research Report) yesterday. The company’s shares closed last Friday at $1.79. According to TipRanks.com, McCarthy is a top 100 analyst with an average return of 56.9%

The SVP and Chief Business Officer of Adamis Pharma (NASDAQ: ADMP) is Selling Shares

On October 1, the SVP and Chief Business Officer of Adamis Pharma (ADMP – Research Report), David Marguglio, sold shares of ADMP for $16K. In addition to David Marguglio, one other ADMP executive reported Sell trades in the last month.

Maxim Group Gives a Buy Rating to Adamis Pharma (ADMP)

Maxim Group analyst Jason McCarthy assigned a Buy rating to Adamis Pharma (ADMP – Research Report) yesterday and set a price target of $1.50. The company’s shares closed last Wednesday at $0.79. According to TipRanks.com, McCarthy is a 5-star analyst

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Adamis Pharma (NASDAQ: ADMP), Aerie Pharma (NASDAQ: AERI) and SELLAS Life Sciences Group (NASDAQ: SLS)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Adamis Pharma (ADMP – Research Report), Aerie Pharma (AERI – Research Report) and SELLAS Life Sciences Group (SLS – Research Report). Adamis Pharma (ADMP) Raymond

Maxim Group Issues a Buy Rating on Adamis Pharma (ADMP)

In a report released today, Jason McCarthy from Maxim Group assigned a Buy rating to Adamis Pharma (ADMP – Research Report), with a price target of $1.50. The company’s shares closed last Tuesday at $0.62. According to TipRanks.com, McCarthy is

A Director at Adamis Pharma (NASDAQ: ADMP) is Buying Shares

Today, a Director at Adamis Pharma (ADMP – Research Report), William Denby, bought shares of ADMP for $9,937. Following this transaction William Denby’s holding in the company was increased by 6.1% to a total of $163.1K. In addition to William